1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. MACROGENICS INC
Macrogenics Inc
XNAS: MGNX

Macrogenics Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Macrogenics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-based therapeutics for the treatment of cancer. The company is currently developing therapeutics utilizing multiple modalities, including antibody-drug conju...

Read More
2.92 -0.09 (-2.99%)
147.46% Gain from 52W Low
177.8K
XNAS Volume

XNAS 07 May, 2026 12:12 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Macrogenics Inc is on 13 May 2026 for the purpose of Macrogenics Inc First Quarter Earnings Result for 2026 See details
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
22.3 / 100
Momentum Score
Technically Moderately Bullish
68.4 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
6
1Yr Price target upside is 105%
4 analysts

6

S

10

W

1

O

3

T

SWOT Analysis

Macrogenics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..